| Literature DB >> 31703618 |
Da-Long Guo1,2, Qiong Li3,4, Xiao-Ru Ji3,4, Zhen-Guang Wang3,4, Yi-He Yu3,4.
Abstract
BACKGROUND: 5-Azacytidine (5-azaC) promotes the development of 'Kyoho' grape berry but the associated changes in gene expression have not been reported. In this study, we performed transcriptome analysis of grape berry at five developmental stages after 5-azaC treatment to elucidate the gene expression networks controlling berry ripening.Entities:
Keywords: 5-azaC; DEG; Grape; Kyoho; Ripening; Transcriptome
Mesh:
Substances:
Year: 2019 PMID: 31703618 PMCID: PMC6839162 DOI: 10.1186/s12864-019-6204-1
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Fig. 1Principal component analysis of the RNA-Seq data. C and A represent the control and the treatment with 100 μM 5-azaC, respectively. The small icon indicates the original samples, the corresponding large icon of the same color and shape indicates the ‘center position’ of the group
Fig. 2GO function enrichment analysis of gene expression at different developmental stages of grape berries. C and A represent the control and the treatment with 100 μM 5-azaC, respectively; the number of genes annotated in specific GO function is expressed as the size of the circle
Fig. 3Grouping optimization of gene expression patterns for TC-seq analysis based on Calinski criterion value
Fig. 4Cluster analysis of the gene expression patterns in the berry of the control and the treatment of ‘Kyoho’ across various developmental stages. Clustering was performed based on TCseq analysis and the number of genes included in each of the clusters is indicated on the top of the figure. The Y axis represents the FPKM values using 2 as the log base of a gene at different developmental stages. The X-axis represents the development stages of the berry. The gray lines indicate the change in gene expression level between samples. The dark purple lines represent the mean of the genes
Fig. 5GO functional enrich analysis of genes in cluster 1 based on TCseq
Numbers of DEGs in each developmental stage or in two adjacent stages of ‘Kyoho’ grape berry for control and 5-azaC treatment
| Name | Up | Down | Total |
|---|---|---|---|
| A1_C1 | 0 | 0 | 0 |
| A2_C2 | 0 | 11 | 11 |
| A3_C3 | 7 | 2 | 9 |
| A4_C4 | 10 | 9 | 19 |
| A5_C5 | 261 | 429 | 690 |
| A_C | 1 | 2 | 3 |
| C1_C2 | 1191 | 932 | 2123 |
| C2_C3 | 1112 | 349 | 1461 |
| C3_C4 | 181 | 424 | 605 |
| C4_C5 | 1381 | 807 | 2188 |
| A1_A2 | 31 | 73 | 104 |
| A2_A3 | 509 | 495 | 1004 |
| A3_A4 | 380 | 224 | 604 |
| A4_A5 | 1862 | 1067 | 2929 |
DEGs were identified according to q < 0.05 and |log2FoldChange| ≥ 1
DEGs between the treatment and the control at the same developmental stage. (q < 0.05)
| Groups | Gene ID | Log2FC | q value | Annotation | KEGG pathway | |
|---|---|---|---|---|---|---|
| A2_C2 | VIT_13s0067g01240 | −5.06 | 5.18E-07 | 0.01143 | Protein EMB-1 | – |
| VIT_12s0028g03260 | −8.26 | 1.95E-06 | 0.021544 | Tyrosine aminotransferase | ||
| VIT_00s1290g00010 | −7.20 | 4.04E-06 | 0.029672 | Endochitinase | – | |
| VIT_05s0029g00200 | −4.71 | 8.23E-06 | 0.030129 | Purple acid phosphatase 15 | – | |
| VIT_11s0052g01230 | −6.63 | 7.97E-06 | 0.030129 | Probable xyloglucan endotransglucosylase | xyloglucan: xyloglucosyl transferase | |
| /hydrolase protein 23 | ||||||
| VIT_15s0048g02530 | −4.64 | 9.56E-06 | 0.030129 | NDR1/HIN1-like protein 12 | – | |
| VIT_19s0015g00540 | −5.83 | 5.65E-06 | 0.030129 | – | – | |
| VIT_00s0450g00010 | −8.23 | 1.26E-05 | 0.031395 | S-linalool synthase | – | |
| VIT_12s0028g01180 | −5.99 | 1.42E-05 | 0.031395 | Non-specific lipid-transfer protein A | – | |
| VIT_14s0128g00200 | −7.09 | 1.29E-05 | 0.031395 | Basic 7S globulin | – | |
| VIT_09s0002g06070 | −4.93 | 2.19E-05 | 0.04396 | Late embryogenesis abundant protein Dc3 | – | |
| A3_C3 | VIT_17s0000g04750 | 1.20 | 4.61E-08 | 0.000642 | UDP-glycosyltransferase 89B2 | – |
| VIT_15s0048g00500 | −1.28 | 9.44E-08 | 0.000658 | Probable pectinesterase/pectinesterase inhibitor 36 | – | |
| VIT_00s0301g00100 | −1.24 | 8.84E-07 | 0.004107 | Endonuclease 1 | – | |
| VIT_05s0049g00770 | 3.26 | 3.39E-06 | 0.00946 | – | – | |
| VIT_13s0064g01760 | 1.59 | 3.14E-06 | 0.00946 | Beta-glucosidase 13 | beta-glucosidase | |
| VIT_18s0001g11860 | 1.46 | 6.06E-06 | 0.012073 | Probable galacturonosyltransferase-like 1 | – | |
| VIT_04s0069g00860 | 2.26 | 1.11E-05 | 0.019415 | Probable sarcosine oxidase | PIPOX; sarcosine oxidase/L- pipecolate oxidase oxidase1111111pipecolapipecolate oxidase pipecolate oxidase | |
| VIT_18s0117g00100 | 6.79 | 2.50E-05 | 0.031624 | – | – | |
| VIT_07s0005g01380 | 2.03 | 4.40E-05 | 0.047143 | Histidine kinase CKl1 | – | |
| A4_C4 | VIT_13s0074g00700 | −2.19 | 3.71E-11 | 5.45E-07 | Pleiotropic drug resistance protein 2 | – |
| VIT_19s0014g00360 | 1.79 | 8.20E-10 | 3.24E-06 | Protein ROOT INITIATION DEFECTIVE 3 | – | |
| VIT_11s0016g02520 | −1.14 | 8.29E-09 | 2.73E-05 | – | – | |
| VIT_13s0067g02710 | 1.78 | 1.62E-08 | 4.58E-05 | – | – | |
| VIT_01s0011g01300 | 1.96 | 2.13E-07 | 0.000468 | Polygalacturonase QRT3 | – | |
| VIT_19s0027g01820 | 2.30 | 1.27E-06 | 0.002514 | Probable potassium transporter 13 | – | |
| VIT_18s0001g08200 | 1.25 | 1.58E-06 | 0.002605 | Protein DETOXIFICATION 48 | TC.MATE, SLC47A, norM, mdtK, dinF; multidrug resistance protein, MATE family | |
| resistance protein, MATE family | ||||||
| VIT_09s0002g00550 | −1.46 | 2.24E-06 | 0.003152 | GDSL esterase/lipase 1 | – | |
| VIT_18s0001g06840 | −3.49 | 2.14E-06 | 0.003152 | Cationic peroxidase 1 | – | |
| VIT_14s0006g02570 | −1.91 | 2.46E-06 | 0.003237 | Non-specific lipid-transfer protein 2 | – | |
| VIT_04s0008g05730 | 1.79 | 4.34E-06 | 0.00476 | Probable sucrose-phosphate synthase 1 | – | |
| VIT_06s0004g04010 | 2.22 | 4.12E-06 | 0.00476 | Exocyst complex component EXO70A1 | EXOC7, EXO70; exocyst complex component 7 | |
| VIT_07s0005g00030 | −1.33 | 4.26E-06 | 0.00476 | Glutathione S-transferase | – | |
| VIT_09s0002g08030 | 1.71 | 5.09E-06 | 0.005292 | Arogenate dehydrogenase 2, chloroplastic | TYRAAT; arogenate dehydrogenase (NADP+), plant | |
| VIT_12s0028g00560 | −4.23 | 7.27E-06 | 0.006841 | – | – | |
| VIT_15s0046g01570 | −4.55 | 7.19E-06 | 0.006841 | Acidic endochitinase | – | |
| VIT_08s0007g01370 | 1.72 | 1.27E-05 | 0.010939 | – | – | |
| VIT_18s0122g01430 | 1.96 | 2.72E-05 | 0.02063 | Probable flavin-containing monooxygenase 1 | FMO; dimethylaniline monooxygenase (N-oxide forming) forming) | |
| forming) | ||||||
| VIT_16s0022g00510 | −1.67 | 4.68E-05 | 0.032756 | 23.6 kDa heat shock protein, mitochondrial | HSP20; HSP20 family protein |
Fig. 6WGCNA of genes for control and treatment at each developmental stages from ‘Kyoho’ grape berry. a Hierarchical cluster tree shows coexpression modules identified by WGCNA. Each leaf represents one gene. The major tree branches constituted 20 modules labeled with different colors. b Module-sample association. Each row corresponds to a module, labeled with a color as in a. Modules are distinguished by different colors which were arbitrarily assigned by the WGCNA package. Each column corresponds to a developmental stage as indicated. The color of each cell at the row-column intersection indicates the correlation coefficient between the module and the developmental stage. A high degree of correlation between a specific module and the developmental is indicated in red
Fig. 7Correlation networks for the lightcyan, darkolivegreen1 and royalblue modules with C2, C3 and A2. Hub genes are indicated by yellow circles. a networks of C2; b networks of C3; c networks of A2
Fig. 8Expression profiles of selected genes from qRT-PCR in the 5-azaC treatment and the control. The x-axis represented different sampling date, while relative expression levels for the y-axis. Data represented the mean of three biological replicates. Error bars represented standard deviations from three independent technical replicates. The asterisks indicate the significant level (*P < 0.05, **P < 0.01) based on a Duncan’s multiple range test
Sampling time points of ‘Kyoho’ grape berries for 5-azaC treatment and the control
| Sampling date (dpa) | |||||
|---|---|---|---|---|---|
| Control | C1 (25) | C2 (35) | C3 (45) | C4 (55) | C5 (65) |
| Treatment | A1 (25) | A2 (35) | A3 (45) | A4 (55) | A5 (65) |
dpa-days post anthesis